Oscar Health, Inc. Second Quarterly 2021 Earnings Conference Call
NEW YORK–(BUSINESS WIRE)–Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack…
Global
Take-Two Interactive Software acquires facial animation services company Dynamixyz
Take-Two Interactive Software (TTWO) announces that it has acquired Dynamixyz, a privately-held companyin video-based facial…
DoubleLine Income Solutions Fund Declares July 2021 Distribution
LOS ANGELES, July 1, 2021 /PRNewswire/ — DoubleLine Income Solutions Fund (the “Fund”), which is traded on the New York Stock…
Used Vehicle Prices Expected to Climb to Record Highs as New Vehicle Prices Stay Steady in Q2, According to Edmunds
SANTA MONICA, Calif., July 1, 2021 /PRNewswire/ — Consumers seeking relief from new car prices in the used car market might…
Cubicle Messiah
One morning a few years ago, as I entered the York Street subway station in Brooklyn, a friendly young woman handed me a promotional…
First National Corporation Completes Acquisition of The Bank of Fincastle
STRASBURG, Va., July 01, 2021 (GLOBE NEWSWIRE) — First National Corporation (NASDAQ: FXNC) (the “Company” or “First National”),…
MainStay MacKay DefinedTerm Municipal Opportunities Fund Declares Monthly Dividend Distributions For The Months Of July, August And September 2021
MainStay MacKay DefinedTerm Municipal Opportunities Fund (the “Fund”) (NYSE:MMD) today announced monthly dividend distributions…
Stock Analysis
U.S Cryptocurrency Miners Fill the Void for Power Solutions Left by China’s Restrictions
NEW YORK, July 1, 2021 /PRNewswire/ — Recently, the price of Bitcoin dropped after orders by local authorities to halt mining…
S&P 500 set to begin second half of 2021 at record open
The S&P 500 index was set to kickoff the second half of the year with a record open on Thursday after data showed fewer-than-expected…
FDA made a mistake in approving a questionable Alzheimer’s drug, but Medicare could act to reduce false hopes and unethical profits
The government should reimburse Biogen only for actual production costs while further clinical trials determine whether aducanumab…